|
|
Article: Gene Logic's Gene Expression Databases Spur Major Drug Discovery Efforts - 24 Programs Underway Across Multiple Disease Areas -.
- Article from:
- PR Newswire
- Article date:
- February 11, 2000
CopyrightCOPYRIGHT 2000 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
GAITHERSBURG, Md., Feb. 11 /PRNewswire/ -- Gene Logic Inc. (Nasdaq: GLGC), the leading provider of gene expression databases, today announced that 24 drug discovery and development programs are underway in the hands of major pharmaceutical companies based on genomic information Gene Logic has developed. This updates the number of 11 programs announced in October 1999, with the majority of the new initiatives commencing in the past quarter. Each of these programs is based on genes discovered by Gene Logic to be associated with the onset and development of important human diseases, such as heart failure, kidney disease, osteoporosis, prostatic hypertrophy, infertility, ...